O3 Changes in gut microbiota after synbiotic supplementation in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial. (23rd March 2020)
- Record Type:
- Journal Article
- Title:
- O3 Changes in gut microbiota after synbiotic supplementation in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial. (23rd March 2020)
- Main Title:
- O3 Changes in gut microbiota after synbiotic supplementation in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
- Authors:
- Widhani, Alvina
Djauzi, Samsuridjal
Suyatna, Fransiscus D
Dewi, Beti Ernawati
Louisa, Melva
Yasmon, Andi
Rahayu, Susan - Abstract:
- Abstract : Background: Systemic lupus erythematosus (SLE) is a chronic multiorgan autoimmune disease with high morbidity. The pathogenesis is multifactorial. Gut dysbiosis plays a role in the pathogenesis of systemic lupus erythematosus (SLE). It can cause systemic inflammation. Methods: We conducted a randomized, double-blind, placebo-controlled trial to investigate whether synbiotic supplementation could improve gut microbiota composition and function in patients with SLE. Results: Forty six SLE patients were randomised to two groups: the synbiotic group received synbiotic capsule ( Lactobacillus helveticus R0052 60%, Bifidobacterium infantis R0033 20%, Bifidobacterium bifidum R0071 20% and 80 mg fructo-oligosaccharides) for 60 days and placebo group. In the synbiotic-supplemented group, 21 patients completed the intervention. In the placebo group, one was excluded from the final analysis because she needed antibiotic treatment for 33 days. We analysed 16s rRNA microbiome data from 89 faecal samples of the 46 patients. We found increases in the Firmicutes to Bacteroidetes ratio, butyrate metabolism and nitrotoluene degradation after synbiotic supplementation. We also found a decrease in potentially pathogenic species and an increase in beneficial species. Conclusion: Synbiotic supplementation affect the composition and functions of gut microbiota in patients with systemic lupus erythematosus.
- Is Part Of:
- Lupus science & medicine. Volume 7(2020)Supplement 1
- Journal:
- Lupus science & medicine
- Issue:
- Volume 7(2020)Supplement 1
- Issue Display:
- Volume 7, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 7
- Issue:
- 1
- Issue Sort Value:
- 2020-0007-0001-0000
- Page Start:
- A8
- Page End:
- A9
- Publication Date:
- 2020-03-23
- Subjects:
- Systemic lupus erythematosus -- Periodicals
616.772005 - Journal URLs:
- http://www.bmj.com/archive ↗
http://lupus.bmj.com/ ↗ - DOI:
- 10.1136/lupus-2020-eurolupus.17 ↗
- Languages:
- English
- ISSNs:
- 2398-8851
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19741.xml